相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis
Claire Bridel et al.
NEUROLOGY (2021)
Serum Contactin-1 in CIDP A Cross-Sectional Study
Luuk Wieske et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)
Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study
Anna He et al.
LANCET NEUROLOGY (2020)
Silent progression in disease activity-free relapsing multiple sclerosis
Bruce A. C. Cree et al.
ANNALS OF NEUROLOGY (2019)
Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Valery L. Feigin et al.
LANCET NEUROLOGY (2019)
Long-term disease activity and disability progression in relapsing-remitting multiple sclerosis patients on natalizumab
I Dekker et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Cytokines and chemokines expression in serum of patients with neuromyelitis optica
Nanping Ai et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2019)
Contactins in the central nervous system: role in health and disease
Madhurima Chatterjee et al.
NEURAL REGENERATION RESEARCH (2019)
Disability Outcome Measures in Phase III Clinical Trials in Multiple Sclerosis
Bernard M. J. Uitdehaag
CNS DRUGS (2018)
Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial
Jerry S. Wolinsky et al.
ANNALS OF NEUROLOGY (2018)
No evident disease activity: The use of combined assessments in the management of patients with multiple sclerosis
Gavin Giovannoni et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
No evident disease activity: The use of combined assessments in the management of patients with multiple sclerosis
Gavin Giovannoni et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Towards personalized therapy for multiple sclerosis: prediction of individual treatment response
Tomas Kalincik et al.
BRAIN (2017)
Long-Term Evolution of Multiple Sclerosis Disability in the Treatment Era
Bruce A. C. Cree et al.
ANNALS OF NEUROLOGY (2016)
EVIDENCE-BASED GUIDELINES MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-establishing disease prognosis and monitoring patients
Mike P. Wattjes et al.
NATURE REVIEWS NEUROLOGY (2015)
A practical guide to immunoassay method validation
Ulf Andreasson et al.
FRONTIERS IN NEUROLOGY (2015)
Sustained disability improvement is associated with T1 lesion volume shrinkage in natalizumab-treated patients with multiple sclerosis
Luca Prosperini et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Age-dependent effects on the treatment response of natalizumab in MS patients
Henrik Matell et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
New Multiple Sclerosis Phenotypic Classification
Fred D. Lublin
EUROPEAN NEUROLOGY (2014)
Defining the clinical course of multiple sclerosis The 2013 revisions
Fred D. Lublin et al.
NEUROLOGY (2014)
Contactin-1 regulates myelination and nodal/paranodal domain organization in the central nervous system
Gulsen Colakoglu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Clinical effects of natalizumab on multiple sclerosis appear early in treatment course
Ludwig Kappos et al.
JOURNAL OF NEUROLOGY (2013)
Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM
Ann C. Kroksveen et al.
JOURNAL OF PROTEOMICS (2013)
Neuro-glial interactions at the nodes of Ranvier: implication in health and diseases
Catherine Faivre-Sarrailh et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2013)
Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis
J. Theodore Phillips et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers
Jan Ottervald et al.
JOURNAL OF PROTEOMICS (2010)
Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis
C. E. Teunissen et al.
NEUROLOGY (2009)
Contactins Emerging key roles in the development and function of the nervous system
Yasushi Shimoda et al.
CELL ADHESION & MIGRATION (2009)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease
C Bjartmar et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2003)
The neuronal adhesion protein TAG-1 is expressed by Schwann cells and oligodendrocytes and is localized to the juxtaparanodal region of myelinated fibers
M Traka et al.
JOURNAL OF NEUROSCIENCE (2002)
Contactin orchestrates assembly of the septate-like junctions at the paranode in myelinated peripheral nerve
MET Boyle et al.
NEURON (2001)
分享论文
